Successful Treatment of Human Fascioliasis with Triclabendazole
Overview
Microbiology
Affiliations
Human Fascioliasis: Report of Two Cases from Kashmir Valley.
Yattoo G, Dar G, Jan K, Sodhi J, Rasool Z, Kaushik S J Clin Exp Hepatol. 2021; 11(6):747-750.
PMID: 34866852 PMC: 8617534. DOI: 10.1016/j.jceh.2020.12.010.
Emerging Cases of Fascioliasis in Lorestan Province, Western Iran: Case Series Report.
Heydarian P, Ashrafi K, Esboei B, Mohe-Bali M, Kia E, Aryaeipour M Iran J Public Health. 2021; 50(1):195-200.
PMID: 34178779 PMC: 8213628. DOI: 10.18502/ijph.v50i1.5087.
Rinaldi L, Folliero V, Restivo L, Foglia F, Franci G, Chianese A Am J Case Rep. 2020; 21:e924704.
PMID: 32936789 PMC: 7520130. DOI: 10.12659/AJCR.924704.
Pattarapuntakul T, Ovartlarnporn B, Rojsanga W, Yungyoo T Case Rep Gastroenterol. 2019; 13(3):438-444.
PMID: 31762732 PMC: 6873016. DOI: 10.1159/000503277.
Clinical presentation and management of Fasciola hepatica infection: single-center experience.
Kaya M, Bestas R, Cetin S World J Gastroenterol. 2011; 17(44):4899-904.
PMID: 22171131 PMC: 3235633. DOI: 10.3748/wjg.v17.i44.4899.